Fidelity Enhanced Large Cap Growth ETF (FELG)

FELG is the sibling of FELC, but pointed in a different direction. Where FELC holds a broad swath of large US companies — value, growth, dividend payers, stalwarts — FELG hunts specifically for growth: companies expanding faster than average, usually at pricier valuations, concentrated in sectors like technology, healthcare, and consumer discretionary where innovation and earnings expansion drive returns. The distinction matters. Growth stocks and value stocks behave differently. Growth can outperform for years, then crash when interest rates rise or investors lose faith in future earnings. FELG bets on growth but tries to do it with disciplined research and valuation awareness, not blind momentum-chasing.

The growth tilt

A large-cap growth fund is, by construction, overweight the sectors and companies that Wall Street believes are growing fastest. Technology is typically 30 to 50 percent of a growth fund’s portfolio, versus maybe 25 percent of the overall market. Healthcare and consumer discretionary are also prominent. Industrial companies, utilities, and energy — which feature more in a broad market index — shrink in proportion.

The logic is simple: if you believe the best long-term returns come from companies growing earnings faster than the average, you own more of them. A company expanding revenue and profit at 15 percent annually is worth more than a utility growing at 2 percent, all else equal. Growth funds make that bet explicit.

FELG’s universe is the largest 500 or so US companies that display growth characteristics. Technology giants like Microsoft, Nvidia, and Tesla fit naturally here. But so do pharmaceutical companies like Eli Lilly, specialty finance firms, and consumer brands betting on innovation. The fund owns fewer old-line energy, financial, and utility stocks — the anchors of value portfolios.

Active management in a growth context

Fidelity’s managers apply research to answer a specific question: Which fast-growing companies are most likely to deliver strong returns over the next few years? This is different from asking which companies are cheapest or most stable. It requires conviction that certain growth stories will pan out — that a healthcare company’s pipeline will succeed, that a software company’s market share will expand, that a consumer brand will gain pricing power.

The managers tilt the portfolio toward their highest-conviction growth plays. They might overweight Nvidia if they believe artificial intelligence spending will accelerate for another decade. They might avoid a tech company they think is facing saturation. They manage the fund not by holding equal amounts of everything in the growth universe but by making deliberate bets on which growth winners will actually win.

This approach carries real execution risk. Growth investing often depends on forward-looking guesses about earnings that have not happened yet. A company can look like a sure winner — all the blogs are bullish, Wall Street is excited, the products are popular — and then stumble if competition emerges or product-development hits a snag. Fidelity’s research process aims to avoid these pitfalls, but they are inherent to growth investing.

Valuation and the cycle

The shadow over any growth fund is valuation. Growth companies trade at higher price-to-earnings multiples than the market average because investors expect higher future earnings growth. This is rational when growth is truly accelerating. But multiples can compress suddenly if growth disappoints or if interest rates rise and make the promise of future growth less attractive.

FELG’s managers pay attention to this. They are not indiscriminate growth-at-any-price buyers; they apply valuation discipline. They will own a company growing at 20 percent even if it trades at a high multiple, because the growth justifies the price. But they will avoid paying 100x earnings for a company growing at 15 percent, figuring the risk-reward is poor. In practice, this means FELG likely owns higher valuations than a broad market index but lower valuations than a pure momentum-chasing growth fund.

This discipline sometimes means underperformance during growth rallies. In 2020 and 2023, growth stocks soared, and the most expensive names outperformed. A fund that was avoiding the most overextended valuations would have lagged. But it also means the fund should theoretically survive a growth-stock correction better than a fund with no valuation guardrails.

Sector concentration and risk

FELG’s growth orientation creates sector concentration. Technology and healthcare will always represent a larger share than in the broad market. This is not hidden risk — it is the stated premise of the fund. You are explicitly buying growth, which means tech-heavy exposure.

Concentration creates volatility. When growth stocks sell off hard — as they did in 2022 and 2024 — a growth fund declines more than the overall market. A broad market index fund would decline, sure, but less dramatically, because it owns value and dividend stocks that held up better. FELG is for investors comfortable with that kind of variability in exchange for the upside if growth continues to dominate.

The other risk is that growth is a cycle, not a trend. There have been long stretches when value beat growth — the 1960s, the 1980s, parts of the 2000s, and 2022. If you were wrong about the structural superiority of growth, FELG would be a drag on your portfolio for years. Timing growth-versus-value is notoriously difficult; betting your core holdings on one or the other can work, or it can be a costly mistake.

Expense ratio and fees

FELG’s expense ratio is similar to FELC — typically 0.50 to 0.65 percent annually. That pays for active management and the daily portfolio adjustments. The question is whether Fidelity’s growth specialists can beat a growth index by more than that cost. Over the long run, active growth managers have a mixed track record. Some years they excel; other years they lag. Over 15+ years, many underperform a passive growth index. But there are exceptions — managers or shops with genuine skill and discipline can persist in beating their benchmarks.

How a reader would evaluate FELG

Start by asking yourself: Do I believe growth stocks will outperform value over my investment horizon? If the answer is no, FELG is the wrong tool. If yes, proceed to: Do I believe active managers can pick growth winners better than a passive growth index?

For the first question, look at historical cycles. Growth and value take turns leading. There is no permanent answer, but your conviction about the next 5 to 10 years should guide whether a growth tilt makes sense for you.

For the second question, check FELG’s track record. Has it beaten the Russell 1000 Growth Index over 5, 10, and 15 years? By how much? Was it due to genuine skill or just lucky sector timing? Read Fidelity’s commentary to understand the philosophy — do their ideas about growth investing resonate with you?

Compare FELG to a passive large-cap growth ETF like IVV Growth or VOV. What is the return differential? Is it enough to justify the slightly higher fee? For most investors, a passive growth fund will be more cost-effective. But for those who have conviction in Fidelity’s research and are willing to pay for active management, FELG offers a disciplined, research-driven approach to growth investing.

Note that FELG is more volatile than FELC, the broad market fund, or any value-focused fund. It is a growth-cycle bet, and you should own it only if you are comfortable with swings. Over a full market cycle, it could outperform or lag by significant margins. That volatility is the price of conviction in growth.